Search
for
Sort by
Research 30 of 1000+
- A Retrospective Analysis from Turkey: The Effect of the COVID-19 Outbreak Quarantine on Dermatology Outpatient Clinics
- INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
- Finasteride Treatment May Not Prevent Telogen Effluvium After Minoxidil Withdrawal
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- AB0389 Methotrexate Treatment for Rheumatoid Arthritis in Poland: Retrospective Analysis of Patients in Routine Clinical Practice
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- Minoxidil vs Finasteride in the Treatment of Men With Androgenetic Alopecia
- Chemical lumbar sympathectomy in the treatment of idiopathic livedo reticularis
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- P146 A multicentre retrospective study evaluating the real-world efficacy and safety of ritlecitinib in the treatment of alopecia areata
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Art of prevention: The importance of dermatologic care when using aromatase inhibitors
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series
- A supplementary report on the toxic manifestations of CHOP regimen in subjects with intermediate grade NHL
- Chemotherapy and Cutaneous Drug Reactions
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- Onychomatricoma: Clinical presentation and management
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Melanin Light Absorption as the Necessary but Not Sufficient Condition for Photoepilation: Miniaturization and Eclipse Phenomena
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Finasteride-associated male infertility
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Pustular Eruption in a Patient Treated With Trametinib
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Cephalalgic Alopecia Areata
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm